Globus Medical (GMED) PT Raised to $65 at Needham & Company
Tweet Send to a Friend
Needham & Company raised its price target on Globus Medical (NYSE: GMED) to $65.00 (from $58.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
